Key Points
- Tenet Healthcare director Nadja West sold 1,152 shares for approximately $298,138, reducing her direct ownership by 4.64% to 23,653 shares.
- Tenet reported quarterly EPS of $6.12, beating estimates by $1.86, while revenue reached $6.04 billion and increased 6.8% year over year.
- Analysts maintain a broadly positive outlook, with a consensus “Buy” rating and an average price target of $273; institutional investors own 95.44% of the stock.
Tenet Healthcare Corporation (NYSE:THC - Get Free Report) Director Nadja West sold 1,152 shares of the stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $258.80, for a total value of $298,137.60. Following the sale, the director directly owned 23,653 shares of the company's stock, valued at $6,121,396.40. The trade was a 4.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Tenet Healthcare Trading Up 2.0%
NYSE:THC opened at $263.64 on Friday. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $283.05. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The stock's 50 day simple moving average is $236.52 and its 200-day simple moving average is $210.85. The firm has a market cap of $21.23 billion, a P/E ratio of 10.17, a PEG ratio of 0.99 and a beta of 1.23.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the company earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities analysts anticipate that Tenet Healthcare Corporation will post 21.04 EPS for the current year.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on THC shares. Wells Fargo & Company boosted their price target on shares of Tenet Healthcare from $231.00 to $281.00 and gave the stock an "overweight" rating in a research note on Monday, August 3rd. The Goldman Sachs Group reiterated a "buy" rating and set a $305.00 target price on shares of Tenet Healthcare in a research report on Tuesday, July 28th. Truist Financial increased their target price on Tenet Healthcare from $270.00 to $290.00 and gave the stock a "buy" rating in a research note on Tuesday, July 28th. Royal Bank Of Canada lifted their price target on Tenet Healthcare from $236.00 to $283.00 and gave the company an "outperform" rating in a research note on Monday, July 27th. Finally, Barclays increased their price objective on Tenet Healthcare from $240.00 to $271.00 and gave the stock an "overweight" rating in a research report on Friday, July 24th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $273.00.
Get Our Latest Report on Tenet Healthcare
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. Triumph Capital Management acquired a new stake in shares of Tenet Healthcare during the 3rd quarter valued at approximately $25,000. Elyxium Wealth LLC purchased a new position in Tenet Healthcare in the 4th quarter valued at approximately $29,000. Canada Pension Plan Investment Board acquired a new position in Tenet Healthcare during the second quarter worth $35,000. Trust Co. of Vermont purchased a new stake in Tenet Healthcare during the second quarter worth $37,000. Finally, Meeder Asset Management Inc. increased its position in shares of Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company's stock valued at $38,000 after buying an additional 114 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.
Tenet Healthcare Company Profile
(
Get Free Report)
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
